Soligenix达成Enrollment里程碑,计划进行Hybryte™治疗皮肤T细胞淋巴瘤的确认性第三阶段临床试验中期分析

美股速递
Nov 19

Soligenix达成Enrollment里程碑,计划进行Hybryte™治疗皮肤T细胞淋巴瘤的确认性第三阶段临床试验中期分析

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10